Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Promino Nutritional Sciences Inc. C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Promino Nutritional Sciences Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(83)
•••
Post by biggonadson Apr 25, 2022 12:53pm
89 Views
Post# 34629403

Growth in global sarcopenia treatment market

Growth in global sarcopenia treatment marketThe global sarcopenia treatment market size is projected to reach $4.7B by 2030 CAGR 6.1%. Element Nutritional Sciences is seriously well positioned to tap into this growing market, and the CDC has named sarcopenia the next osteoporosis. ELMT’s impressive and patented portfolio boasts some ready-to-drink products that are clinically proven in effectively fighting Sarcopenia and preventing age-related muscle loss. Furthermore, measured against its competitors their Rejuvenate product is scoring superior across all metrics. Already distributed at over 16k+ retail points with a recent Publix distro update, they also have potential to expand into institutional and healthcare markets as well. https://www.youtube.com/watch?v=XKbbYLnZn40
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities